ZA944686B - Process for producing hydrophobic polypeptides proteins or peptides - Google Patents
Process for producing hydrophobic polypeptides proteins or peptidesInfo
- Publication number
- ZA944686B ZA944686B ZA944686A ZA944686A ZA944686B ZA 944686 B ZA944686 B ZA 944686B ZA 944686 A ZA944686 A ZA 944686A ZA 944686 A ZA944686 A ZA 944686A ZA 944686 B ZA944686 B ZA 944686B
- Authority
- ZA
- South Africa
- Prior art keywords
- peptides
- proteins
- hydrophobic polypeptides
- producing hydrophobic
- polypeptides proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93110755 | 1993-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA944686B true ZA944686B (en) | 1995-01-06 |
Family
ID=8213046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA944686A ZA944686B (en) | 1993-07-06 | 1994-06-29 | Process for producing hydrophobic polypeptides proteins or peptides |
Country Status (14)
Country | Link |
---|---|
US (1) | US5750374A (ru) |
EP (2) | EP0641861B1 (ru) |
JP (2) | JP2947401B2 (ru) |
CN (3) | CN100439391C (ru) |
AT (1) | ATE236984T1 (ru) |
AU (1) | AU666274B2 (ru) |
CA (1) | CA2125467C (ru) |
DE (1) | DE69432449T2 (ru) |
DK (1) | DK0641861T3 (ru) |
ES (1) | ES2194017T3 (ru) |
NZ (1) | NZ260907A (ru) |
PT (1) | PT641861E (ru) |
RU (1) | RU94023251A (ru) |
ZA (1) | ZA944686B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817626A (en) * | 1995-03-14 | 1998-10-06 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation |
US6303567B1 (en) | 1995-03-14 | 2001-10-16 | Praecis Pharmaceuticals, Inc . | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
WO1996028471A1 (en) | 1995-03-14 | 1996-09-19 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
US5854215A (en) * | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals Incorporated | Modulators of β-amyloid peptide aggregation |
GB9618952D0 (en) | 1996-09-11 | 1996-10-23 | Sandoz Ltd | Process |
US5985242A (en) * | 1995-10-27 | 1999-11-16 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US6277826B1 (en) | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
CA2362834C (en) | 1999-03-04 | 2005-12-06 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
EP1187920A2 (en) | 1999-06-09 | 2002-03-20 | Arch Development Corporation | Recombinant prion-like genes and proteins and materials and methods comprising same |
EP1226241A1 (en) * | 1999-10-21 | 2002-07-31 | Panorama Research, Inc. | A general method for optimizing the expression of heterologous proteins |
US7799561B2 (en) * | 2002-06-12 | 2010-09-21 | Sigma-Aldrich, Co. | Affinity peptides and method for purification of recombinant proteins |
FR2859221B1 (fr) * | 2003-08-28 | 2005-10-14 | Centre Nat Rech Scient | Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations |
US7741053B2 (en) * | 2005-05-13 | 2010-06-22 | Sigma-Aldrich Co. | Processes for purification of recombinant proteins |
KR100621354B1 (ko) * | 2005-06-14 | 2006-09-08 | 광주과학기술원 | 유비퀴틴을 이용한 아밀로이드-베타 펩티드의 제조방법 |
WO2010063460A1 (en) * | 2008-12-02 | 2010-06-10 | Universität Zürich | Recombinant production of hydrophobic peptides and fusion proteins for use in producing same |
US20170226159A1 (en) * | 2014-09-26 | 2017-08-10 | Kaneka Corporation | Method for producing hydrophobic peptide |
EP3227455B1 (en) | 2014-12-01 | 2023-07-12 | Pfenex Inc. | Fusion partners for peptide production |
CN105001307B (zh) | 2015-07-31 | 2016-08-24 | 南京斯拜科生化实业有限公司 | 一种溶解难溶多肽的偶联肽链及其在液相色谱中分离纯化的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0207044A1 (en) * | 1985-06-20 | 1986-12-30 | Monsanto Company | Release of peptides from polypeptides |
ES2000859A6 (es) * | 1985-08-12 | 1988-03-16 | Syntex Inc | Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion |
DE3788397T3 (de) * | 1986-03-24 | 2003-11-27 | Ortho Pharmaceutical Corp., Raritan | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. |
US5047513A (en) * | 1986-07-10 | 1991-09-10 | Hoffmann-La Roche Inc. | Metal chelate resins |
CA1304886C (en) * | 1986-07-10 | 1992-07-07 | Heinz Dobeli | Metal chelate resins |
EP0289110A3 (en) * | 1987-02-02 | 1990-01-24 | Swiss Serum and Vaccine Institute Berne | Conjugate malaria vaccine |
CA1340522C (en) * | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
US5416007A (en) * | 1987-03-20 | 1995-05-16 | Creative Biomolecules, Inc. | Enhanced proteolytic cleavage of recombinant fusion proteins |
US5124255A (en) * | 1988-03-11 | 1992-06-23 | Abbott Laboratories | CKS method of protein synthesis |
IT1226728B (it) * | 1988-08-05 | 1991-02-05 | Eniricerche Spa | Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso |
US5045190A (en) * | 1988-11-08 | 1991-09-03 | Carbonell Ruben G | Chromatography apparatus |
AU646877B2 (en) * | 1990-06-15 | 1994-03-10 | Scios Nova Inc. | Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
EP0546101A1 (en) * | 1990-08-24 | 1993-06-16 | The President And Fellows Of Harvard College | METHOD OF INTERFERING WITH FORMATION OF $g(a)-ANTICHYMOTRYPSIN-$g(b)-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
EP0770679B2 (de) * | 1990-11-03 | 2009-12-30 | Siemens Healthcare Diagnostics Products GmbH | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung |
NZ243636A (en) * | 1991-07-29 | 1993-06-25 | Iaf Biochem Int | Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11 |
US5434050A (en) * | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
-
1994
- 1994-06-08 CA CA002125467A patent/CA2125467C/en not_active Expired - Fee Related
- 1994-06-23 DK DK94109676T patent/DK0641861T3/da active
- 1994-06-23 AT AT94109676T patent/ATE236984T1/de not_active IP Right Cessation
- 1994-06-23 DE DE69432449T patent/DE69432449T2/de not_active Expired - Fee Related
- 1994-06-23 EP EP94109676A patent/EP0641861B1/en not_active Expired - Lifetime
- 1994-06-23 ES ES94109676T patent/ES2194017T3/es not_active Expired - Lifetime
- 1994-06-23 PT PT94109676T patent/PT641861E/pt unknown
- 1994-06-23 EP EP03000052A patent/EP1304381A3/en not_active Withdrawn
- 1994-06-29 ZA ZA944686A patent/ZA944686B/xx unknown
- 1994-06-29 US US08/268,348 patent/US5750374A/en not_active Expired - Fee Related
- 1994-07-01 AU AU66122/94A patent/AU666274B2/en not_active Ceased
- 1994-07-01 NZ NZ260907A patent/NZ260907A/en not_active IP Right Cessation
- 1994-07-04 CN CNB99101393XA patent/CN100439391C/zh not_active Expired - Fee Related
- 1994-07-04 CN CNA2006101006833A patent/CN1916017A/zh active Pending
- 1994-07-04 CN CN94108110A patent/CN1057535C/zh not_active Expired - Fee Related
- 1994-07-04 RU RU94023251/13A patent/RU94023251A/ru unknown
- 1994-07-05 JP JP6153161A patent/JP2947401B2/ja not_active Expired - Fee Related
-
1998
- 1998-02-12 JP JP10030205A patent/JPH1143500A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2194017T3 (es) | 2003-11-16 |
DK0641861T3 (da) | 2003-07-28 |
PT641861E (pt) | 2003-07-31 |
JP2947401B2 (ja) | 1999-09-13 |
CN1227846A (zh) | 1999-09-08 |
CA2125467C (en) | 2001-02-06 |
EP1304381A2 (en) | 2003-04-23 |
DE69432449T2 (de) | 2004-04-08 |
EP0641861B1 (en) | 2003-04-09 |
EP0641861A2 (en) | 1995-03-08 |
NZ260907A (en) | 1996-06-25 |
CN100439391C (zh) | 2008-12-03 |
CA2125467A1 (en) | 1995-01-07 |
AU666274B2 (en) | 1996-02-01 |
ATE236984T1 (de) | 2003-04-15 |
CN1916017A (zh) | 2007-02-21 |
EP1304381A3 (en) | 2003-05-02 |
EP0641861A3 (en) | 1997-07-30 |
JPH07102000A (ja) | 1995-04-18 |
RU94023251A (ru) | 1996-05-10 |
JPH1143500A (ja) | 1999-02-16 |
CN1098416A (zh) | 1995-02-08 |
US5750374A (en) | 1998-05-12 |
AU6612294A (en) | 1995-01-27 |
CN1057535C (zh) | 2000-10-18 |
DE69432449D1 (de) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA944686B (en) | Process for producing hydrophobic polypeptides proteins or peptides | |
DE69020143D1 (de) | Verfahren zur verwendung und herstellung von peptiden. | |
AU7566396A (en) | Process for the preparation of peptides by way of streptavidin fusion proteins | |
NZ224057A (en) | A polypeptide of a vascular anticoagulant protein and method of preparation | |
CA2220447A1 (en) | Novel fusion protein recovery and purification methods | |
HUT55800A (en) | Process for producing anticoagulant peptides | |
GR3025978T3 (en) | Ryegrass pollen allergen | |
AU3825389A (en) | Hcg peptides for use in antibody purification procedures | |
DE69010155D1 (de) | Verfahren zur Trennung von Aminosäuren. | |
DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
HU896448D0 (en) | Process for the preparation of anticoagulant peptides | |
AU7193296A (en) | Process for the ultrafiltration of biological matrices comprising peptides or proteins | |
ATE189232T1 (de) | Protein-s polypeptide und deren verwendungen | |
GB2248839B (en) | Process for the separation of proteins or polypeptides | |
EP0425892A3 (en) | Process for enhancing the bioavailability of drugs with peptide bonds | |
DE59004279D1 (de) | Verfahren zur C-terminalen Modifizierung von Proteinen. | |
MX9701904A (es) | Proteinas de enlace de pka novedosas y usos de las mismas. | |
NO901842D0 (no) | Rekombinante fusjonsproteiner for endring av hormonutskillelse. | |
IL112663A0 (en) | Modelling of the three-dimensional structure of peptides, polypeptides and proteins |